Department of Urology, Dow Division of Health Services Research The University of Michigan, Ann Arbor, MI.
Department of Urology, Dow Division of Health Services Research The University of Michigan, Ann Arbor, MI.
Urology. 2014 Jul;84(1):57-61. doi: 10.1016/j.urology.2014.04.008.
To determine the effect of an ambulatory surgery center (ASC) opening in a healthcare market on utilization and quality of outpatient urologic surgery.
This is a retrospective cohort study of Medicare beneficiaries undergoing outpatient urologic surgery from 2001 to 2010. Markets were classified into 3 groups based on ASC status (ie, those with ASCs, those without ASCs, and those where ASCs were introduced). Multiple propensity score methods adjusted for differences between markets and general linear mixed models determined the effect of ASC opening on utilization and quality, defined by mortality and hospital admission within 30 days of the index procedure.
During the study period, 195 ASCs opened in markets previously without one. Rates of hospital-based urologic surgery in markets where ASCs were introduced declined from 221 to 214 procedures per 10,000 beneficiaries in the 4 years after baseline. In contrast, rates in the other 2 market types increased over the same period (P<.001). Rates of outpatient urologic surgery overall (ie, in the hospital and ASC) demonstrated similar growth across market types during same period (P=.56). The introduction of an ASC into a market was not associated with increases in hospital admission or mortality (P>.5).
The introduction of an ASC into a healthcare market lowered rates of outpatient urologic surgery performed in the more expensive hospital setting. This redistribution was not associated with declines in quality or with greater growth in overall outpatient surgery use.
确定在医疗市场中开设门诊手术中心(ASC)对门诊泌尿外科手术的利用和质量的影响。
这是一项对 2001 年至 2010 年间接受门诊泌尿外科手术的 Medicare 受益人的回顾性队列研究。根据 ASC 状态(即有 ASC、无 ASC 和引入 ASC 的市场)将市场分为 3 组。采用多种倾向评分方法调整市场之间和一般线性混合模型的差异,确定 ASC 开设对利用和质量的影响,质量由术后 30 天内的死亡率和住院率定义。
在研究期间,有 195 个 ASC 在以前没有 ASC 的市场中开设。在基线后 4 年内,引入 ASC 的市场中基于医院的泌尿外科手术率从每 10000 名受益人的 221 例下降到 214 例。相比之下,其他 2 种市场类型在此期间均有所增加(P<.001)。同期,总体门诊泌尿外科手术(即医院和 ASC)的比例也表现出相似的增长(P=.56)。引入 ASC 到市场与住院率或死亡率的增加无关(P>.5)。
在医疗市场中引入 ASC 降低了在更昂贵的医院环境中进行的门诊泌尿外科手术的比例。这种重新分配与质量下降或总体门诊手术使用的更大增长无关。